Skip to content Skip to sidebar Skip to footer

Newsletter

Small Caps Stocks

5 ASX stocks at risk of delisting in the next 6 months

A couple of weeks ago, a list of ASX stocks at risk of delisting was released on the market announcements platforms. The ASX has the right to remove stocks for breaking listing rules (such as failing to lodge the report) or if it is appropriate for some other reason. But it was rare to see…

ByNick SundichSeptember 15, 2025

Zenith Minerals Shares Soar 116% on Red Mountain Gold Breakthrough

Zenith Mineral Red Mountain Drilling Results Signal Potential High-Grade Gold System Zenith Minerals (ASX: ZNC) delivered a market jolt this week, with shares opening 116 percent higher to 13 cents after releasing the first assays from its 2025 drilling campaign at the Red Mountain project in Queensland. The results point to both strong grades and…

ByCharlie YouldenSeptember 11, 2025

Imagion Biosystems (ASX:IBX) gets ready for Phase 2

It's taken a while to get here, but the US medical device company Imagion Biosystems (ASX: IBX), which listed on the ASX way back in June 2017, is now getting to a really interesting stage of its clinical development, and has just raised $3.5m at 1.5 cents per share to fund this stage. Imagion Biosystems was…

ByNick SundichSeptember 11, 2025

Plenti (ASX:PLT): Offering investors exposure to the energy transition, but without the high capex

Plenti (ASX:PLT) is not just another small cap lender - it could be the best way to gain exposure to the energy transition. Because it is a lender focused on lending to renewable energy, as well as to consumers for automotives and personal loans. But it is the first of these that has won it…

ByNick SundichSeptember 11, 2025

Emyria’s (ASX:EMD) commercial breakthrough in psychedelic medicine

When Perth-based Emyria (ASX:EMD) announced on 18 June that Medibank would be funding eligible customer participation in Emyria's Post-Traumatic Stress Disorder care programme, with no out-of-pocket costs, investors who know the Life Sciences sector needed to sit up and take notice. Here was Australia's largest health insurer, with over 4.2 million customers, saying that it…

ByStuart RobertsSeptember 10, 2025

OFX (ASX:OFX): After backflipping on its growth promises and spending months in the doldrums, maybe there’s light at the end of the tunnel?

OFX (ASX:OFX) shares shed more than two thirds of their value from October 2024 to June 2025 after a weak trading update. But its most recent trading update has shown there might be hope for shareholders. OFX Share price chart, log scale (Source: Google) Introduction to OFX OFX was founded in 1998 by Matthew Gilmour and Gary…

ByNick SundichSeptember 10, 2025

Why SenSen (ASX: SNS) Shares Fell 23% on Positive Deal News

SenSen Networks: Solid Wins, Tough Market Reaction SenSen Networks (ASX: SNS) opened sharply lower today, even after announcing fresh contract wins worth a combined AUD 2 million in FY26. The stock’s 23 percent drop has left many investors questioning why good news translated into heavy selling. On paper, the update looked strong. SenSen secured a…

ByCharlie YouldenSeptember 9, 2025

Brazilian Rare Earths (ASX: BRE): Early Moves in a Global Growth Market

Brazilian Rare Earths (ASX: BRE) – Final Permit Secures Path to Pilot Plant Operations Brazilian Rare Earths (ASX: BRE) has been one of the market’s standout movers, soaring 42% percent in the last 5 days after securing final approval for its rare earths pilot plant in Bahia. This green light from Brazil’s National Authority on…

ByCharlie YouldenSeptember 9, 2025

Actinogen Medical (ASX:ACW): Will history repeat itself? Can it bounce back from a troublesome Phase 2 trial?

Actinogen Medical (ASX:ACW) is the poster child for how volatile biotech stocks can be. the last time we wrote about this company was in August last year when shares more than halved after results of a Phase II trial that investors perceived to be a flop. But the company has soldiered on and has a…

ByNick SundichSeptember 9, 2025

Here’s what investors need to know about ReRAM and how ASX chip stocks can make big bucks from it!

Our longer term readers would know we are big fans of Weebit Nano (ASX:WBT), a company commercialising its own version of a technology known as ReRAM (Resistive Random-Access Memory). We've spoken a lot about Weebit and certain other chip stocks embracing it (which we'll get into shortly), but we've never written an article focused on…

ByNick SundichSeptember 8, 2025